NCT05185492Recruiting
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
Source: ClinicalTrials.gov · Last updated 20 Mar 2026
Brief summary (registry, in English)
This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care centers. As the first true North American multicenter CS collaborative with a uniform dedicated and comprehensive case report form, the high patient volumes and wide spectrum of clinical acuity seen at these institutions will provide valuable insight into the factors associated with adverse outcomes; and will serve as a blueprint for future clinical trial designs that may better inform clinical practice.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 22 Dec 2021
- Start date
- 25 May 2022
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- STAVROS G DRAKOS
- Diseases
- Coronary artery disease
- NCT number
- NCT05185492
What you commit to
- Study type: Observational
- Planned participants: 500
- From 25 May 2022 to the primary completion date, 31 Dec 2027
- 3 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with shock not due to primary cardiac etiology will be excluded. These include septic, hemorrhagic, and anaphylactic shock.
Who the study is looking for
- Primary diagnosis of cardiogenic shock at time of index evaluation; including acute myocardial infarction- and acute decompensated heart failure-cardiogenic shock phenotypes
- Patients with cardiac arrest complicating cardiogenic shock and those with massive pulmonary embolism with right ventricular cardiogenic shock will also be eligible for the registry
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Toronto Coordinator of this site? Confirm its status | Toronto | Canada | Recruiting |
| Inova Heart and Vascular Institute Coordinator of this site? Confirm its status | Falls Church | United States | Recruiting |
| Cleveland Clinic Florida Coordinator of this site? Confirm its status | Weston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.